Adaptive Biotechnologies Corp (OQ:ADPT)

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for ADPT within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 23rd, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 20/20 Feb 19/20 Robins Harlan S Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -7,400  
Feb 20/20 Feb 19/20 Robins Harlan S Direct Ownership Common Stock S - Open market or private sale -3,900 $33.21
Feb 20/20 Feb 19/20 Robins Harlan S Direct Ownership Common Stock S - Open market or private sale -3,500 $32.18
Feb 20/20 Feb 19/20 Robins Harlan S Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 7,400 $6.32
Feb 20/20 Feb 19/20 Rubinstein Julie Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -55,000  
Feb 20/20 Feb 19/20 Rubinstein Julie Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -25,000  
Feb 20/20 Feb 19/20 Rubinstein Julie Direct Ownership Common Stock S - Open market or private sale -80,000 $33.00
Feb 20/20 Feb 19/20 Rubinstein Julie Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 55,000 $0.840
Feb 20/20 Feb 19/20 Rubinstein Julie Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 25,000 $0.840
Feb 20/20 Feb 18/20 Robins Harlan S Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -18,500  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for ADPT within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 23rd, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 20/20 Feb 19/20 Robins Harlan S Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -7,400  
Feb 20/20 Feb 18/20 Robins Harlan S Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -18,500  
Feb 20/20 Feb 19/20 Robins Harlan S Direct Ownership Common Stock S - Open market or private sale -3,900 $33.21
Feb 20/20 Feb 19/20 Robins Harlan S Direct Ownership Common Stock S - Open market or private sale -3,500 $32.18
Feb 20/20 Feb 19/20 Robins Harlan S Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 7,400 $6.32
Feb 20/20 Feb 18/20 Robins Harlan S Direct Ownership Common Stock S - Open market or private sale -18,500 $31.38
Feb 20/20 Feb 18/20 Robins Harlan S Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 18,500 $6.32
Feb 20/20 Feb 19/20 Rubinstein Julie Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -55,000  
Feb 20/20 Feb 19/20 Rubinstein Julie Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -25,000  
Feb 20/20 Feb 19/20 Rubinstein Julie Direct Ownership Common Stock S - Open market or private sale -80,000 $33.00
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $ADPT

Competitors

Competitors with Recent Insider Filings
Guardant Health (OQ:GH)
Veracyte (OQ:VCYT)
InVitae (N:NVTA)